Research Catalog

Guidance for industry : E14 clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs, questions and answers.

Title
Guidance for industry : E14 clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs, questions and answers.
Publication
Silver Spring, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research, [2008]

Available Online

https://purl.fdlp.gov/GPO/LPS117596

Details

Additional Authors
Center for Biologics Evaluation and Research (U.S.)
Description
1 online resource (7 pages)
Alternative Title
E14 clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs, questions and answers
Subject
  • Drugs > Testing > Government policy > United States
  • Palpitation
Note
  • "ICH."
  • "November 2008."
Call Number
GPO Internet HE 20.4702:C 61/6
OCLC
marcive477248560
Title
Guidance for industry : E14 clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs, questions and answers.
Publisher
Silver Spring, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research, [2008]
Type of Content
text
Type of Medium
computer
Type of Carrier
online resource
Connect to:
https://purl.fdlp.gov/GPO/LPS117596
Added Author
Center for Biologics Evaluation and Research (U.S.)
Gpo Item No.
0499-T (online)
Sudoc No.
HE 20.4702:C 61/6
View in Legacy Catalog